Daiwa Securities Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
EAM
Daiwa Securities Group's COLL Position: Q1 2026 in Review
Daiwa Securities Group sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 67 shares — an estimated $3K sold.
Daiwa Securities Group first reported a position in COLL in Q1 2018 and held it in 32 quarters. The position peaked at $5K in Q3 2024. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Daiwa Securities Group reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 67 Collegium Pharmaceutical shares in Q1 2026, an estimated $3K.
- Daiwa Securities Group first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Collegium Pharmaceutical position peaked at $5K in Q3 2024.
- 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.